division of antivirals

AMA Update 127: The FDA on Molnupiravir and COVID-19: What physicians need to know, Part III

18 de febrero de 2022 casimedicos 00:12:33 0 Comments

In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.

AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

15 de febrero de 2022 casimedicos 00:14:49 0 Comments

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.